Comparison of irinotecan and oxaliplatin as the first-line therapies for metastatic colorectal cancer: a meta-analysis

BACKGROUND: Irinotecan (IRI) and oxaliplatin (Ox) are standard therapeutic agents of the first-line treatments for metastatic colorectal cancer (mCRC). Previous meta-analyses of randomized controlled trials (RCTs) showed that treatment with Ox-based compared with IRI-based regimens was associated wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawai, Sadayuki, Takeshima, Nozomi, Hayasaka, Yu, Notsu, Akifumi, Yamazaki, Mutsumi, Kawabata, Takanori, Yamazaki, Kentaro, Mori, Keita, Yasui, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863255/
https://www.ncbi.nlm.nih.gov/pubmed/33541293
http://dx.doi.org/10.1186/s12885-021-07823-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863255/
https://www.ncbi.nlm.nih.gov/pubmed/33541293
http://dx.doi.org/10.1186/s12885-021-07823-7

Ejemplares similares